Stock 6108 NEW RAY MEDICINE INTERNATIONAL HOLDING LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company New Ray Medicine International Holding Limited

Equities

6108

BMG647461117

Drug Retailers

Delayed Hong Kong S.E.
Other stock markets
 09:08:20 14/05/2024 BST 		5-day change 1st Jan Change
0.054 HKD -8.47% Intraday chart for New Ray Medicine International Holding Limited +35.00% +8.00%
03-25 New Ray Medicine International Holding Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-18 New Ray Medicine International Forecasts Decline in 2023 Loss MT

Business Summary

New Ray Medicine International Holding Limited is an investment holding company principally engaged in the trading of pharmaceutical products in China. The Company operates its business through four segments. The Injection Drugs segment is engaged in the trading of injection drugs. The Capsule and Granule Drugs segment is engaged in the trading of capsule and granule drugs. The Tablet Drugs segment is engaged in the trading of tablet drugs. The Others segment is engaged in the trading of miscellaneous types of goods and drugs.

Number of employees: 23

Sales per Business

HKD in Million2022Weight2023Weight Delta
Distribution and Trading of Pharmaceutical Products
85.4 %
84 93.3 % 43 85.4 % -48.84%
Provision of Marketing and Promotion Services
14.6 %
6 6.7 % 7 14.6 % +21.36%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
100.0 %
90 100.0 % 50 100.0 % -44.13%

Managers

Managers TitleAgeSince
Qiuqin Wang CEO
 Chief Executive Officer 46 26/06/18
Zhi Hong Huo BRD
 Director/Board Member 45 26/06/18
Yat Sing Ng SEC
 Corporate Secretary - 10/07/23

Members of the board

Members of the board TitleAgeSince
Lai Yin Sy BRD
 Director/Board Member 44 23/09/18
Chi Kin Leung BRD
 Director/Board Member 74 25/09/13
Sin Ming Li BRD
 Director/Board Member 48 19/06/17
Zhi Hong Huo BRD
 Director/Board Member 45 26/06/18
Qiuqin Wang CEO
 Chief Executive Officer 46 26/06/18
Xue Ping Chu BRD
 Director/Board Member 52 17/06/21
Wan Zhou BRD
 Director/Board Member 34 30/03/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,671,846,657 964,022,657 ( 57.66 %) 0 57.66 %

Shareholders

NameEquities%Valuation
Xue Ping Chu
25.52 %
426,672,000 25.52 % 2 M $

Company contact information

New Ray Medicine International Holding Ltd.

B-C, 37th Floor Dikai International Center

311112, Hangzhou

+

http://www.newraymedicine.com
address New Ray Medicine International Holding Limited(6108)

Sector

Consumer Non-Cyclicals
Food & Drug Retailing
Food & Drug Retailing
Drug Retailers
Other Drug Retailers

Sales per Business

Annual profits - Rate of surprise

Company calendar

Sector Other Drug Retailers

1st Jan change Capi.
NEW RAY MEDICINE INTERNATIONAL HOLDING LIMITED Stock New Ray Medicine International Holding Limited
+8.00% 11.56M
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-29.72% 15.83B
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-22.89% 12.31B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-24.53% 6.59B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
+15.23% 6.45B
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-12.43% 5.94B
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
-1.90% 4.66B
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+62.00% 4.59B
CLICKS GROUP LIMITED Stock Clicks Group Limited
-5.94% 3.96B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD. Stock DaShenLin Pharmaceutical Group Co., Ltd.
-9.36% 3.55B
Other Drug Retailers
  1. Stock Market
  2. Equities
  3. 6108 Stock
  4. Company New Ray Medicine International Holding Limited